☆ 4.8 Editorial Material

Novel approaches to detecting tau pathology

NATURE MEDICINE (2015)

期刊

NATURE MEDICINE

卷 21, 期 3, 页码 219-220

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/nm.3809

关键词

-

类别

Biochemistry & Molecular Biology Cell Biology Medicine, Research & Experimental

向作者/读者索取更多资源

Protocol

Reagent

摘要

Tau pathology is commonly analyzed by positron emission tomography (PET) imaging. However, recently developed cell-based techniques for analyzing tau pathogenicity may also be used to measure an early biomarker in tauopathies.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Neurosciences

Tau antibody 77G7 targeting microtubule binding domain suppresses proteopathic tau to seed tau aggregation

Longfei Li, Jin Miao, Dandan Chu, Nana Jin, Yunn Chyn Tung, Chun-Ling Dai, Wen Hu, Cheng-Xin Gong, Khalid Iqbal, Fei Liu

Summary: Findings from this study suggest that the monoclonal tau antibody 77G7 effectively suppresses the seeding activity of AD O-tau and could potentially be developed as an immunotherapeutic drug to inhibit the propagation of tau pathology in AD and related tauopathies.

CNS NEUROSCIENCE & THERAPEUTICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

A novel dephosphorylation targeting chimera selectively promoting tau removal in tauopathies

Jie Zheng, Na Tian, Fei Liu, Yidian Zhang, Jingfen Su, Yang Gao, Mingmin Deng, Linyu Wei, Jingwang Ye, Honglian Li, Jian-Zhi Wang

Summary: The novel DEPTAC designed and synthesized in this study effectively dephosphorylates tau at AD-associated sites and prevents its accumulation. DEPTAC improves microtubule assembly, synaptic plasticity, and hippocampus-dependent learning and memory, providing a new strategy for the targeted therapy of AD and related tauopathies.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Clinical Neurology

Profiling and predicting distinct tau progression patterns: An unsupervised data-driven approach to flortaucipir positron emission tomography

Duygu Tosun, Pamela Thropp, Sudeepti Southekal, Bruce Spottiswoode, Rachid Fahmi

Summary: This study used an unsupervised data-driven whole-brain pattern analysis to identify distinct tau accumulation profiles and build baseline models predictive of tau-accumulation type. Screening for fast tau accumulation and A beta positivity in early Alzheimer's disease requires a lower sample size to achieve 80% power for a specific treatment.

ALZHEIMERS & DEMENTIA (2023)

添加到收藏夹

Review Neurosciences

Limitations of human tau-expressing mouse models and novel approaches of mouse modeling for tauopathy

Naruhiko Sahara, Rin Yanai

Summary: Neurofibrillary tangles composed of hyperphosphorylated tau protein are key features of tauopathy. However, there is a limited number of animal models that display intracellular tau pathology. Recent studies have shown that transgenic mice expressing mutant tau successfully develop neurofibrillary pathology, but there are limitations and pitfalls to be addressed.

FRONTIERS IN NEUROSCIENCE (2023)

添加到收藏夹

Review Pharmacology & Pharmacy

Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives

Teresa Pardo-Moreno, Anabel Gonzalez-Acedo, Antonio Rivas-Dominguez, Victoria Garcia-Morales, Francisco Jose Garcia-Cozar, Juan Jose Ramos-Rodriguez, Lucia Melguizo-Rodriguez

Summary: This article discusses the treatment approaches for Alzheimer's disease, including approved drugs, investigational therapies, and alternative methods to improve lifestyle.

PHARMACEUTICS (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Acetylated tau inhibits chaperone-mediated autophagy and promotes tau pathology propagation in mice

Benjamin Caballero, Mathieu Bourdenx, Enrique Luengo, Antonio Diaz, Peter Dongmin Sohn, Xu Chen, Chao Wang, Yves R. Juste, Susanne Wegmann, Bindi Patel, Zapporah T. Young, Szu Yu Kuo, Jose Antonio Rodriguez-Navarro, Hao Shao, Manuela G. Lopez, Celeste M. Karch, Alison M. Goate, Jason E. Gestwicki, Bradley T. Hyman, Li Gan, Ana Maria Cuervo

Summary: The study shows that acetylation of tau protein reduces its degradation through chaperone-mediated autophagy, leading to rerouting to other autophagic pathways and increased extracellular release of tau.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Nonlocal models in the analysis of brain neurodegenerative protein dynamics with application to Alzheimer's disease

Swadesh Pal, Roderick Melnik

Summary: In this paper, a multiscale model is proposed to analyze the spreading patterns of toxic concentrations of amyloid-beta and tau proteins in the brain connectome. The study shows that the spreading patterns are the same for the whole brain, but the concentrations differ in different regions.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review

Tien-Wei Yu, Hsien-Yuan Lane, Chieh-Hsin Lin

Summary: Alzheimer's disease is a progressive neurodegenerative disease that presents a heavy burden on families and society. Current treatments are not effective, prompting the urgent need for novel therapeutic approaches to address the complex mechanisms of the disease. Potential interventions include drug repositioning and non-pharmacological treatments like repetitive transcranial magnetic stimulation and transcranial direct current stimulation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Clinical Neurology

Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice

Shuai Zhao, Ziqi Fan, Xinyi Zhang, Zheyu Li, Ting Shen, Kaicheng Li, Yaping Yan, Yunfeng Yuan, Jiali Pu, Jun Tian, Zhirong Liu, Yanxing Chen, Baorong Zhang

Summary: This study found that metformin can inhibit the propagation of tau protein in Alzheimer's disease and reduce its hyperphosphorylation. It also improves learning and memory deficits, suggesting that metformin could be a promising drug for the prevention and early treatment of AD.

NEUROTHERAPEUTICS (2023)

添加到收藏夹

Article Clinical Neurology

Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals

Pamela C. L. Ferreira, Joseph Therriault, Cecile Tissot, Joao Pedro Ferrari-Souza, Andrea L. Benedet, Guilherme Povala, Bruna Bellaver, Douglas T. Leffa, Wagner S. Brum, Firoza Z. Lussier, Gleb Bezgin, Stijn Servaes, Marie Vermeiren, Arthur C. Macedo, Arlec Cabrera, Jenna Stevenson, Gallen Triana-Baltzer, Hartmuth Kolb, Nesrine Rahmouni, William E. Klunk, Oscar L. Lopez, Victor L. Villemagne, Ann Cohen, Dana L. Tudorascu, Eduardo R. Zimmer, Thomas K. Karikari, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Serge Gauthier, Pedro Rosa-Neto, Tharick A. Pascoal

Summary: This study evaluated the contribution of plasma phosphorylated tau (p-tau) biomarkers to identifying Aβ and tau pathologies. It found that plasma p-tau231 and p-tau217 improved the performance of identifying Aβ deposition, but did not provide additional information for identifying tau tangles.

ALZHEIMERS & DEMENTIA (2023)

添加到收藏夹

Article Biophysics

TAUCON and TAUCOM: A novel biosensor based on fluorescence resonance energy transfer for detecting tau hyperphosphorylation-associated cellular pathologies

Sanghyun Ahn, Jung -Soo Suh, Yoon-Kwan Jang, Heonsu Kim, Kiseok Han, Yerim Lee, Gyuho Choi, Tae-Jin Kim

Summary: The TAUCON and TAUCOM biosensors, based on fluorescence resonance energy transfer (FRET), can accurately detect abnormal conformational changes in tau protein at the single-cell level. These biosensors provide valuable tools for investigating the initial causes, mechanisms, progression, and treatment of tauopathies.

BIOSENSORS & BIOELECTRONICS (2023)

添加到收藏夹

Article Neurosciences

Aggrecan modulates the expression and phosphorylation of tau in a novel bigenic TauP301L-Acan mouse model

Sophie Schmidt, Caroline Stapf, Sandra Schmutzler, Ingolf Lachmann, Thomas Arendt, Max Holzer, Mandy Sonntag, Markus Morawski

Summary: Selected neurons in the central nervous system are surrounded by perineuronal nets (PNs) which regulate plasticity and synaptic physiology. Research showed that aggrecan, a component of PNs, has a neuroprotective role by preventing internalization of pathological tau forms. However, in a mouse model, reduced aggrecan levels led to increased tau protein and phosphorylation, suggesting a correlation between aggrecan and tau pathology triggered by mutation.

EUROPEAN JOURNAL OF NEUROSCIENCE (2021)

添加到收藏夹

Article Cell Biology

Laser-Induced Axotomy of Human iPSC-Derived and Murine Primary Neurons Decreases Somatic Tau and AT8 Tau Phosphorylation: A Single-Cell Approach to Study Effects of Acute Axonal Damage

M. Bell-Simons, S. Buchholz, J. Klimek, H. Zempel

Summary: This study used a laser-based axotomy model combined with confocal microscopy to investigate the distribution of Tau protein in axons and its relationship with protein transport. The results suggest that axonal damage does not lead to the accumulation of Tau protein in the cell body or an increase in AT8 Tau phosphorylation.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2023)

添加到收藏夹

Article Geriatrics & Gerontology

Two simple assays for assessing the seeding activity of proteopathic tau

Fei Liu, Ruozhen Wu, Nana Jin, Dandan Chu, Jianlan Gu, Yunn Chyn Tung, Zhihao Hu, Cheng-Xin Gong, Khalid Iqbal

Summary: Two simple assays, capture assay and seeded-tau aggregation assay, were developed to assess tau seeding activity. These assays were proven to be specific and sensitive and can be carried out in a regular biomedical laboratory setting.

FRONTIERS IN AGING NEUROSCIENCE (2023)

添加到收藏夹

Review Oncology

Uterine serous carcinoma: key advances and novel treatment approaches

J. Stuart Ferriss, Britt K. Erickson, Ie-Ming Shih, Amanda N. Fader

Summary: The incidence and mortality rates of endometrial cancer are increasing globally, with uterine serous carcinoma responsible for a large proportion of deaths despite being a small fraction of cases. Molecular analysis has identified major alterations, and surgery remains a cornerstone of treatment. Targeted therapies, including anti-HER2 treatments and combinations like pembrolizumab and lenvatinib, show promise for improving outcomes in women with this aggressive subtype of endometrial cancer.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

添加到收藏夹

Article Clinical Neurology

Genome-wide association study and functional validation implicates JADE1 in tauopathy

Kurt Farrell, SoongHo Kim, Natalia Han, Megan A. Iida, Elias M. Gonzalez, Marcos Otero-Garcia, Jamie M. Walker, Timothy E. Richardson, Alan E. Renton, Shea J. Andrews, Brian Fulton-Howard, Jack Humphrey, Ricardo A. Vialle, Kathryn R. Bowles, Katia de Paiva Lopes, Kristen Whitney, Diana K. Dangoor, Hadley Walsh, Edoardo Marcora, Marco M. Hefti, Alicia Casella, Cheick T. Sissoko, Manav Kapoor, Gloriia Novikova, Evan Udine, Garrett Wong, Weijing Tang, Tushar Bhangale, Julie Hunkapiller, Gai Ayalon, Robert R. Graham, Jonathan D. Cherry, Etty P. Cortes, Valeriy Y. Borukov, Ann C. McKee, Thor D. Stein, Jean-Paul Vonsattel, Andy F. Teich, Marla Gearing, Jonathan Glass, Juan C. Troncoso, Matthew P. Frosch, Bradley T. Hyman, Dennis W. Dickson, Melissa E. Murray, Johannes Attems, Margaret E. Flanagan, Qinwen Mao, M-Marsel Mesulam, Sandra Weintraub, Randy L. Woltjer, Thao Pham, Julia Kofler, Julie A. Schneider, Lei Yu, Dushyant P. Purohit, Vahram Haroutunian, Patrick R. Hof, Sam Gandy, Mary Sano, Thomas G. Beach, Wayne Poon, Claudia H. Kawas, Maria M. Corrada, Robert A. Rissman, Jeff Metcalf, Sara Shuldberg, Bahar Salehi, Peter T. Nelson, John Q. Trojanowski, Edward B. Lee, David A. Wolk, Corey T. McMillan, C. Dirk Keene, Caitlin S. Latimer, Thomas J. Montine, Gabor G. Kovacs, Mirjam Lutz, Peter Fischer, Richard J. Perrin, Nigel J. Cairns, Erin E. Franklin, Herbert T. Cohen, Towfique Raj, Inma Cobos, Bess Frost, Alison Goate, Charles L. White, John F. Crary

Summary: The study found that Primary age-related tauopathy (PART) has a genetic architecture that partially overlaps with Alzheimer's disease (AD) and other tauopathies, and suggests a novel role for JADE1 as a modifier of neurofibrillary degeneration.

ACTA NEUROPATHOLOGICA (2022)

添加到收藏夹

Article Clinical Neurology

Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations

Cyril Pottier, Ligia Mateiu, Matthew C. Baker, Mariely DeJesus-Hernandez, Cristina Teixeira Vicente, NiCole A. Finch, Shulan Tian, Marka van Blitterswijk, Melissa E. Murray, Yingxue Ren, Leonard Petrucelli, Bjorn Oskarsson, Joanna M. Biernacka, Neill R. Graff-Radford, Bradley F. Boeve, Ronald C. Petersen, Keith A. Josephs, Yan W. Asmann, Dennis W. Dickson, Rosa Rademakers

Summary: By comparing gene expression, the researchers found that patients with GRN mutations and those with unknown mutations have similar transcriptional profiles, involving several potentially druggable pathways. These findings reveal novel disease mechanisms in FTLD and strongly suggest that GRN mutations extend beyond GRN and contribute to genetically unexplained forms of FTLD.

BRAIN (2022)

添加到收藏夹

Article Neuroimaging

TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration

Marina Buciuc, Peter R. Martin, Nirubol Tosakulwong, Melissa E. Murray, Leonard Petrucelli, Matthew L. Senjem, Anthony J. Spychalla, David S. Knopman, Bradley F. Boeve, Ronald C. Petersen, Joseph E. Parisi, R. Ross Reichard, Dennis W. Dickson, Clifford R. Jack, Jennifer L. Whitwell, Keith A. Josephs

Summary: The study found differences and similarities in longitudinal brain volume loss between FTLD-TDP and non-FTLD TDP-43, with faster atrophy rates in certain brain regions for FTLD-TDP and faster hippocampal atrophy rates in AD-TDP type-a.

NEUROIMAGE-CLINICAL (2022)

添加到收藏夹

Article Neurosciences

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition

Sheelakumari Raghavan, Scott A. Przybelski, Robert Reid, Timothy G. Lesnick, Vijay K. Ramanan, Hugo Botha, Billie J. Matchett, Melissa E. Murray, R. Ross Reichard, David S. Knopman, Jonathan Graff-Radford, David T. Jones, Val J. Lowe, Michelle M. Mielke, Mary M. Machulda, Ronald C. Petersen, Kejal Kantarci, Jennifer L. Whitwell, Keith A. Josephs, Clifford R. Jack, Prashanthi Vemuri

Summary: Multi-compartment modelling of white matter microstructure using NODDI can provide valuable information for distinguishing the underlying substrate for cognitive impairment in older adults. The study found distinct NODDI readouts of white matter damage associated with different diseases, which are informative for identifying cognitive impairment.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

添加到收藏夹

Article Clinical Neurology

Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease

Vijay K. Ramanan, Michael G. Heckman, Timothy G. Lesnick, Scott A. Przybelski, Elliot J. Cahn, Matthew L. Kosel, Melissa E. Murray, Michelle M. Mielke, Hugo Botha, Jonathan Graff-Radford, David T. Jones, Val J. Lowe, Mary M. Machulda, Clifford R. Jack, David S. Knopman, Ronald C. Petersen, Owen A. Ross, Prashanthi Vemuri

Summary: This study found that a polygenic risk score (PRS) based on tau PET can effectively capture tau deposition levels and genetic background influencing tau accumulation. It outperformed amyloid PET burden and APOE ε4 in capturing tau deposition. The tau PRS was also associated with cerebrospinal fluid phosphorylated tau levels and postmortem neurofibrillary tangle stage. Additionally, it showed an interaction with amyloid burden on cognitive decline.

ACTA NEUROPATHOLOGICA (2022)

添加到收藏夹

Letter Clinical Neurology

Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia

Arenn F. Carlos, Nirubol Tosakulwong, Stephen D. Weigand, Bradley F. Boeve, David S. Knopman, Ronald C. Petersen, Aivi Nguyen, R. Ross Reichard, Melissa E. Murray, Dennis W. Dickson, Keith A. Josephs

ACTA NEUROPATHOLOGICA (2022)

添加到收藏夹

Editorial Material Neurosciences

Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies

Alexis Moscoso, Melissa C. Wren, Tammaryn Lashley, Erik Arstad, Melissa E. Murray, Nick C. Fox, Kerstin Sander, Michael Scholl

MOLECULAR NEURODEGENERATION (2022)

添加到收藏夹

Article Clinical Neurology

Phosphorylated tau sites that are elevated in Alzheimer's disease fluid biomarkers are visualized in early neurofibrillary tangle maturity levels in the post mortem brain

Christina M. Moloney, Sydney A. Labuzan, Julia E. Crook, Habeeba Siddiqui, Monica Castanedes-Casey, Christian Lachner, Ronald C. Petersen, Ranjan Duara, Neill R. Graff-Radford, Dennis W. Dickson, Michelle M. Mielke, Melissa E. Murray

Summary: This study aims to characterize the recognition of phosphorylated tau sites in early neurofibrillary tangle maturity levels, which may explain why these fluid biomarkers can be observed before symptom onset.

ALZHEIMERS & DEMENTIA (2023)

添加到收藏夹

Article Chemistry, Organic

Comparison of [18F]F-CNBI and [18F]F-CNPIFE as Positron Emission Tomography Probes for Noninvasive Imaging of Glycogen Synthase Kinase-3 in Normal Mice

Heather M. Stein, Surendra R. Gundam, Aditya Bansal, Nicholas R. Nelson, Geoffry L. Curran, Timothy R. DeGrado, Mark A. Frye, John D. Port, Val J. Lowe, Melissa E. Murray, Mukesh K. Pandey

Summary: This study synthesized two PET probes and evaluated their permeability through the blood-brain barrier and affinity towards GSK-3 alpha/beta. The results showed that [F-18]F-CNPIFE had higher brain uptake compared to [F-18]F-CNBI, making it a promising PET probe for imaging GSK-3 alpha/beta.

EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2023)

添加到收藏夹

Article Clinical Neurology

LATE-NC staging in routine neuropathologic diagnosis: an update

Peter T. Nelson, Edward B. Lee, Matthew D. Cykowski, Irina Alafuzoff, Konstantinos Arfanakis, Johannes Attems, Carol Brayne, Maria M. Corrada, Brittany N. Dugger, Margaret E. Flanagan, Bernardino Ghetti, Lea T. Grinberg, Murray Grossman, Michel J. Grothe, Glenda M. Halliday, Masato Hasegawa, Suvi R. K. Hokkanen, Sally Hunter, Kurt Jellinger, Claudia H. Kawas, C. Dirk Keene, Naomi Kouri, Gabor G. Kovacs, James B. Leverenz, Caitlin S. Latimer, Ian R. Mackenzie, Qinwen Mao, Kirsty E. McAleese, Richard Merrick, Thomas J. Montine, Melissa E. Murray, Liisa Myllykangas, Sukriti Nag, Janna H. Neltner, Kathy L. Newell, Robert A. Rissman, Yuko Saito, S. Ahmad Sajjadi, Katherine E. Schwetye, Andrew F. Teich, Dietmar R. Thal, Sandra O. Tome, Juan C. Troncoso, Shih-Hsiu J. Wang, Charles L. White III, Thomas Wisniewski, Hyun-Sik Yang, Julie A. Schneider, Dennis W. Dickson, Manuela Neumann

Summary: This report updates the neuropathologic criteria for diagnosing and staging LATE-NC and provides practical suggestions for integrating genetic information and comorbid pathologies. It also highlights recent research findings that improve differentiation of LATE-NC from other subtypes of TDP-43 pathology and offers guidance for diagnosing unusual cases. Additionally, the report describes the neuroanatomical regions of interest in LATE-NC and specifies the implications for TDP-43 immunohistochemical results. The report emphasizes unresolved questions and areas requiring further study.

ACTA NEUROPATHOLOGICA (2022)

添加到收藏夹

Article Neurosciences

Accumulation of pTau231 at the Postsynaptic Density in Early Alzheimer's Disease

Jaclyn Lilek, Kaouther Ajroud, Alexander Z. Feldman, Sesha Krishnamachari, Shadi Ghourchian, Tamar Gefen, Callen L. Spencer, Allegra Kawles, Qinwen Mao, Jessica F. Tranovich, Clifford R. Jack, M-Marsel Mesulam, R. Ross Reichard, Hui Zhang, Melissa E. Murray, David Knopman, Dennis W. Dickson, Ronald C. Petersen, Benjamin Smith, Karen H. Ashe, Michelle M. Mielke, Kathryn M. Nelson, Margaret E. Flanagan

Summary: Phosphorylated cytoplasmic tau inclusions are correlated with and precede cognitive deficits in Alzheimer's Disease (AD). The results also indicate that the frontal cortex represents early AD, while entorhinal total tau levels are significantly higher in amnestic mild cognitive impairment compared to AD.

JOURNAL OF ALZHEIMERS DISEASE (2023)

添加到收藏夹

Article Neurosciences

Global neuropathologic severity of Alzheimer's disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

Melissa E. Murray, Christina M. Moloney, Naomi Kouri, Jeremy A. Syrjanen, Billie J. Matchett, Darren M. Rothberg, Jessica F. Tranovich, Tiffany N. Hicks Sirmans, Heather J. Wiste, Baayla D. C. Boon, Aivi T. Nguyen, R. Ross Reichard, Dennis W. Dickson, Val J. Lowe, Jeffrey L. Dage, Ronald C. Petersen, Clifford R. Jack Jr, David S. Knopman, Prashanthi Vemuri, Jonathan Graff-Radford, Michelle M. Mielke

Summary: The study found that soluble plasma phosphorylated tau levels are associated with Alzheimer's disease-related neuropathological changes, particularly with the deposition of amyloid-beta and tau proteins in the brain. Additionally, other pathological changes such as locus coeruleus degeneration may also be associated with plasma phosphorylated tau levels.

MOLECULAR NEURODEGENERATION (2022)

添加到收藏夹

Article Neurosciences

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins

Stephanie R. Oatman, Joseph S. Reddy, Zachary Quicksall, Minerva M. Carrasquillo, Xue Wang, Chia-Chen Liu, Yu Yamazaki, Thuy T. Nguyen, Kimberly Malphrus, Michael Heckman, Kristi Biswas, Kwangsik Nho, Matthew Baker, Yuka A. Martens, Na Zhao, Jun Pyo Kim, Shannon L. Risacher, Rosa Rademakers, Andrew J. Saykin, Michael DeTure, Melissa E. Murray, Takahisa Kanekiyo, Dennis W. Dickson, Guojun Bu, Mariet Allen, Niluefer Ertekin-Taner

Summary: By integrating genetic information and data on neurobiochemical markers, we identified seven novel loci and the APOE locus that are associated with Alzheimer's disease. These loci and genes are also related to other relevant variables, gene expression, brain health, and other neuropsychiatric diseases.

MOLECULAR NEURODEGENERATION (2023)

添加到收藏夹

Review Neurosciences

The hippocampal sparing subtype of Alzheimer's disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review

Daniel Ferreira, Rosaleena Mohanty, Melissa E. Murray, Agneta Nordberg, Kejal Kantarci, Eric Westman

Summary: This study examines different subtypes of Alzheimer's disease (AD) using neuropathology and neuroimaging techniques, and finds that tau PET can identify hippocampal sparing AD cases with neurofibrillary tangles (NFT) completely sparing the hippocampus.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

添加到收藏夹

Meeting Abstract Clinical Neurology

Frequency and Distribution of Transactive Response DNA-Binding Protein 43 (TDP-43) Pathology Across the Age Spectrum in an Elderly Cohort with and without Dementia

Arenn Faye Carlos, Nirubol Tosakulwong, Stephen D. Weigand, Bradley F. Boeve, David S. Knopman, Ronald C. Petersen, Aivi Nguyen, Ross Reichard, Melissa E. Murray, Dennis W. Dickson, Keith A. Josephs

ANNALS OF NEUROLOGY (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.